Stockscreener 앱 받기
203.46
3.13%
6.18
시간 외 거래:
202.93
-0.53
-0.26%
전일 마감가:
$197.28
열려 있는:
$197.78
하루 거래량:
13.07M
Relative Volume:
0.81
시가총액:
$81.23B
수익:
$2.23B
순이익/손실:
$-3.19B
주가수익비율:
-24.98
EPS:
-8.1462
순현금흐름:
$-1.60B
1주 성능:
+11.45%
1개월 성능:
+47.45%
6개월 성능:
+310.53%
1년 성능:
+703.24%
1일 변동 폭
$190.00
$208.90
1주일 범위
$180.39
$208.90
52주 변동 폭
$22.28
$208.90
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
Compare MRNA vs VRTX, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
203.46 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
VRTX
Vertex Pharmaceuticals Inc
|
526.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
750.51 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
970.66 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.48 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-28 | 재개 | Barclays | Equal Weight |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-12 | 개시 | Jefferies | Hold |
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
The first mRNA flu vaccine is now available for older adults. Here’s what to know - KCRA
Biotech Stocks To Follow TodaySeptember 27th - MarketBeat
Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem - GuruFocus
MODERNA INC (MRNA-USD.SW) - Yahoo! Finance Canada
Top Healthcare Stocks To ConsiderSeptember 26th - MarketBeat
Moderna Stock (MRNA) Opinions on Cancer Vaccine Phase 3 Success - Quiver Quantitative
Moderna CEO’s Realistic Approach to Innovation - WSJ
Top Biotech Stocks To Add to Your WatchlistSeptember 26th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Moderna Inc Lobbyists, 2026 - OpenSecrets
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
Stock Traders Purchase Large Volume of Call Options on Moderna (NASDAQ:MRNA) - MarketBeat
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today? - Yahoo Finance
Promising Healthcare Stocks To ResearchSeptember 25th - MarketBeat
Moderna stock last at USD 199.29 in New York trading - ad-hoc-news.de
Moderna Stock Reached New 52-Week High: What's Happening? - Benzinga
Moderna Rallies 39 Percent as Small Cap Healthcare Stocks Surge - SuaraGarut.ID
Bernstein reiterates Moderna stock rating on mRNA platform progress - Investing.com
Bernstein reiterates Moderna stock rating on mRNA platform progress By Investing.com - Investing.com Canada
Moderna Stock Forecast: MRNA Hits 52-Week High as Melanoma Vaccine Drives Rally - FXLeaders
Moderna stock gains 6.98 percent near its 52-week high - AD HOC NEWS
MRNA Looks 710.7% Overvalued on GF Value™ - GuruFocus
Moderna, Inc. Stock Analysis: Momentum Builds Amid Overbought Signals - The Cryptonomist
Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24. - TIKR.com
Moderna, Inc. (NASDAQ:MRNA) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Moderna stock heads into the open after a 6.98 percent gain - AD HOC NEWS
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better - Yahoo Finance
Moderna Stock Trends After HoursModerna (NASDAQ:MRNA), Merck & Co (NYSE:MRK) - Benzinga
Why is Moderna (MRNA) Stock Trending After Hours? - TradingView
Moderna Inc. R (0QF.DU) stock price, news, quote and history - Yahoo Finance Australia
$Moderna (MRNA.US)$ thanks - Moomoo
Moderna Inc. (MRNA) Holds High-Level Investment Talks With UAE, Soars to 4-Year Peak - Yahoo Finance
From $63 To $195: Moderna’s Two-Month Rerating Isn’t Done - Yahoo Finance
Moderna Rises as Cancer-Vaccine Momentum and Pipeline Visibility Stay in Focus - Quiver Quantitative
Moderna, Inc. (MRNA) Options ChainYahoo Finance - Yahoo! Finance Canada
Moderna Inc Stock (MRNA) Moved Up by 5.91% on Sep 24: What Investors Need To Know - TradingKey
Moderna's View of the Global Pharma Industry - WSJ
Top Biotech Stocks To Keep An Eye OnSeptember 24th - MarketBeat
A New Cancer Vaccine Shows Promise for Melanoma—Here’s What Doctors Know So Far - elle.com
Moderna stock trades below its 52-week high before cancer data - AD HOC NEWS
Dear Doctor: Should I hold off on my flu shot until I'm eligible for the new version? - syracuse.com
Biotech Stocks At 52-Week HighsTKNO, MRNA, ATRC, ILMN - RTTNews
Nykredit A S Acquires New Holdings in Moderna, Inc. $MRNA - MarketBeat
Engineers Gate Manager LP Cuts Holdings in Moderna, Inc. $MRNA - MarketBeat
Moderna Inc (MRNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Moderna stock gains 4.5 percent ahead of the open - ad-hoc-news.de
Why Did META, MRNA, OKTA Stocks Surge To 52-Week Highs Today? - Yahoo Finance
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines - Barron's
Moderna stock rises 5.6 percent at the close - AD HOC NEWS
Healthcare Stocks Fall -- Healthcare Roundup - marketscreener.com
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID - TradingView
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
모더나 주식 (MRNA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Hoge Stephen | President |
Sep 15 '26 |
Option Exercise |
12.21 |
76,452 |
933,479 |
1,602,310 |
| Hoge Stephen | President |
Sep 15 '26 |
Sale |
146.07 |
40,281 |
5,883,846 |
1,562,029 |
| Hoge Stephen | President |
Sep 14 '26 |
Sale |
144.13 |
40,294 |
5,807,574 |
1,525,858 |
0.23%
1.36%
자본화:
|
볼륨(24시간):